Marta Tibiletti1, Jo Naish1,2, John C Waterton1,3, Paul JC Hughes4, James A Eaden4, Jim M Wild4, and Geoff JM Parker1,5
1Bioxydyn Ltd, Manchester, United Kingdom, 2MCMR, Manchester University NHS Foundation Trust, Manchester, United Kingdom, 3Centre for Imaging Sciences,, University of Manchester, Manchester, United Kingdom, 4POLARIS, Imaging Sciences, Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom, 5Centre for Medical Image Computing, University College London, London, United Kingdom
Synopsis
In this work, we explore the possibility of extracting
a population Arterial Input Function (AIF) to be used in the quantification of lung perfusion using
T1-weighted contrast
agent-based perfusion imaging. The population AIF averages the shape of first pass of the CA
bolus at high temporal resolution in the pulmonary arteries from 90 scans acquired in 50 patients with
interstitial lung
disease. The population AIF is then scaled by the patient weight. The results
of the analysis using a measured AIF and the population AIF are compared.
Introduction
T1-weighted contrast agent (CA)-based perfusion
imaging characterizes the first pass of a CA bolus through the
lung, allowing for the measurement of blood flow, blood volume and mean transit
time [1].
One
of the method’s challenges is the accurate extraction of the Arterial Input Function (AIF), the concentration of CA in the feeding
artery. Some of the issues that may arise include: curve sampling at too low
temporal resolution; errors in the peak height
due to signal saturation at high CA concentrations; incomplete spoiling;
partial volume and inflow effects; and motion.
Previous investigators have used consensus
or population-based AIF in the analysis of extended
dynamic contrast-enhanced MR data [2]. However, it is not known whether
population-based AIFs are also useful in perfusion imaging based on first-pass
DCE-MRI.
In this work, we explore the possibility of extracting
a population AIF for lung perfusion imaging, detailing the first pass of the CA
bolus at high temporal resolution in the pulmonary arteries (PA). The results
of the analysis using a measured AIF and the population AIF are compared.Methods:
51 patients with interstitial lung disease
underwent thoracic perfusion MRI at 1.5 T (Signa HDxt GE).
The study protocol comprised 2 MRI scans, 6 weeks or 6 months apart depending
on the specific diagnosis. A total of 90 scans were available at the time of
writing. The MR protocol comprised four coronal fast 3D SPGR variable flip
angle datasets to calculate baseline T1 (TE/TR= 0.9/2.85 ms, BW= 62.5 kHz, FOV=
48 cm, acquisition matrix 200x80x60, FA= 2,4,10,30 deg). These were followed by
a view-sharing dynamic acquisition (TE/TR= 0.7/2 ms, FA= 20⁰, BW= 125 kHz, FOV= 48 cm, matrix=
200x80x24, temporal phases= 48, acquisition time per frame 0.56 s, ASSET/SENSE
factor= 2, turbo mode= 2). At the start of this acquisition, a bolus injection
of 0.06 mL/kg gadoteric acid (Dotarem, Guerbet, Villepinte, France) was
administered in the left antecubital vein by a power injector at 2 mL/s
followed by a saline flush at 4 mL/s. All images were acquired at end
expiration breath hold.
Lungs were manually segmented and an ROI in the
main trunk of the PA was defined to derive individual AIFs. Signal curves were
converted into concentration-time curves and the AIFs (CAIF(t)) were fitted by a gamma
variate (GV) curve described by the following equation[3]:
\begin{cases}0 & t< t_{start}\\ \frac{AUC}{C^{B+1}B^B\sqrt{\pi B}e^{-B+1/(12B)}} \cdot ({t-t_{start} })^B \cdot e^{(\frac{t-t_{start}}{C})}&t\geq t_{start}\end{cases}
where parameters B, C define the shape of the curve, tstart is
the distance between the start of the acquisition and the start of the curve. AUC
is the area under the concentration-time curve. The
resulting fitted AIFs (with tstart=0 and AUC=1) were
averaged to obtain a population AIF (figure 1). The relationship between each
AIF and dose was determined by linear regression of the AUC against dose, based
on the known relationship between cardiac output and weight [4]. The correlation between the AIF GV
parameters (C,B) and dose was calculated (Pearson correlation), to determine if
these also vary with dose.
Data from each patient were then analysed twice, with the
individual measured AIF and the population AIF, scaled for dose, as input.
Concentration-time curves in the lung were also fitted with the GV prior to the
analysis.
Blood volume was calculated as $$$BV=\frac{\intop\nolimits_{0}^{\infty}C(t)dt}{\intop\nolimits_{0}^{\infty} C_{AIF}(t)dt}$$$. Blood Flow (BF) was determined
by deconvolution of CAIF(t)
from C(t) according to indicator
dilution theory. Mean transit time was defined as MTT = BV/BF.
Mean and std values over the whole lung
for BV, MTT and BF obtained with the two AIFs were compared using a paired t-testResults
The obtained population AIF is visualized
in figure 1. The linear regression between dose and measured AUC is visualized
in figure 2. The parametrization of the individual
AIFs (parameters B and C) did not show any significant correlation with injected
volume of contrast agent (p=0.45, p=0.82). The resulting patients’ BV, MTT and BF distributions obtained with the two AIFs are shown in figure 3, while an example of the perfusion maps obtained in a subject is presented in figure 4. Over the group as a whole, BV is higher if calculated with a measured AIF than with the population AIF (0.41± 0.17 100ml/100ml, vs 0.35 ± 0.12 100ml/100ml, p-value=0.001). MTT (measured AIF: 4.29 ± 0.92 s, population AIF: 4.21 ± 1.15 s, p-value= 0.219) and BF (measured AIF: 0.0095 ± 0.046 100ml/100ml/s, population AIF: 0.877± 0.035 100ml/100ml/s, p-value=0.08).Comments
A population AIF was obtained from the
PA. While there is significant variation among the GV fitting from which the
population AIF was obtained, the variation is not related to dose, however, the
AUC is linearly related to dose. When comparing the results of the perfusion
analysis within our patient population, the only significant difference was
observed in in BV, which is lower when calculated using a population AIF. This
is probably due to some of the measured AIF presenting an AUC that is too low
in comparison to the patients data.Conclusion
In this work, we have derived a
population AIF for perfusion quantification in the lung. This AIF may be of use
in settings where measured AIF quality is insufficient to allow reliable quantification.Acknowledgements
The
research leading to these results received funding from the Innovative
Medicines Initiatives 2 Joint Undertaking under grant agreement No 116106. This
Joint Undertaking receives support from the European Union’s Horizon 2020
research and innovation programme and EFPIA.
References
(1): Sourbron, Steven P., and David L. Buckley. "Classic models for
dynamic contrast‐enhanced MRI." NMR in Biomedicine 26.8 (2013): 1004-1027.
(2) : Parker GJ, Roberts C, Macdonald A,
Buonaccorsi GA, Cheung S, Buckley DL, Jackson A, Watson Y, Davies K, Jayson GC.
Experimentally-derived functional form for a population-averaged
high-temporal-resolution arterial input function for dynamic contrast-enhanced
MRI. Magn Reson Med 2006;56(5):993-1000.
(3) Li, Xingfeng, Jie Tian,
and R. K. Millard. "Erroneous and inappropriate use of gamma fits to
tracer-dilution curves in magnetic resonance imaging and nuclear
medicine." Magnetic resonance imaging 21.9 (2003): 1095-1096.
(4) Evans JM, Wang S, Greb
C, et al. Body Size Predicts Cardiac and Vascular Resistance Effects on Men's
and Women's Blood Pressure. Front Physiol. 2017;8:561. Published 2017 Aug 9.
doi:10.3389/fphys.2017.00561